mTOR, a Potential Target to Treat Autism Spectrum Disorder

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|5|533-543

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.5, 2016-05, pp. : 533-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1045-1061

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-08 ,pp. : 373-389

Bentham Science Publishers

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors: Potential Uses and a Review of Haematological Adverse Effects

By Sofroniadou Sofia   Goldsmith David  

Drug Safety, Vol. 34, Iss. 2, 2011-02 ,pp. : 97-115

Adis International

Access to resources Recommend Favorite

The mTOR protein as a target in thyroid cancer

By Souza Elaine Cristina Lima de   Ferreira Andrea Claudia Freitas   Carvalho Denise Pires de  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. : 1099-1112

Informa Healthcare

Access to resources Recommend Favorite

An overview of the mTOR pathway as a target in cancer therapy

By Gentzler Ryan D   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite